Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?

Metabolic Brain Disease

Volumn 13, Issue 4, 1998, Pages 351-360

  Jones, E Anthony ^a   Basile, Anthony S ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; AMMONIA; BENZODIAZEPINE RECEPTOR;

BRAIN METABOLISM; CONFERENCE PAPER; GABAERGIC SYSTEM; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; NEUROMODULATION; PATHOPHYSIOLOGY; RECEPTOR DENSITY;

AMMONIA; ANIMALS; BEHAVIOR, ANIMAL; ELECTROPHYSIOLOGY; GAMMA-AMINOBUTYRIC ACID; HUMANS; LIVER FAILURE; NERVOUS SYSTEM; NEUROTRANSMITTER AGENTS; SYNAPTIC TRANSMISSION;

EID: 0032408483     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020693026810     Document Type: Conference Paper

References (46)

1. Akwa, Y., Sananes, N., Gouezou, M., Robel, P., Baulieu, E.E. and Le Goascogne, C. (1993). Astrocytes and neurosteroids: metabolism of pregnenolone and dehydro-epiandrosterone. Regulation by cell density. J. Cell. Biol. 12:135-143.
2. Bakti, G., Fisch, H.U., Karlaganis, G., Minder, C. and Bircher, J. (1987). Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam. Hepatology 7:629-638.
3. Bansky, G., Meier, P.J., Ziegler, W.H., Walser, H., Schmid, M. and Huber, M. (1985). Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1: 1324-1325.
4. Basile, A.S. and Skolnick, P. (1986). Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain. J. Neurochem. 46:305-308.
5. Basile, A.S., Gammal, S.H., Mullen, K.D., Jones, E.A. and Skolnick, P.(1988). Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J. Neurosci. 8:2414-2421.
6. Basile, A.S., Gammal, S.H., Jones, E.A. and Skolnick, P.(1989). The GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J. Neurochem. 53:1057-1063.
7. A receptor complex in hepatic encephalopathy: autoradiographic evidence for the presence of an endogenous benzodiazepine receptor ligand. Neuropsychopharmacology 3:61-71.
8. Basile, A.S., Pannell, L., Jaouni, T., Gammal, S.H., Fales, H., Jones, E.A. and Skolnick, P. (1990b). Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Proc. Natl. Acad. Sci. USA 87:5263-5267.
9. Basile, A.S. (1991). The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy. Synapse 7:141-150.
10. Basile, A.S., Hughes, R.D., Harrison, P.M., Murata, Y., Pannell, L., Jones, E.A. et al. (1991). Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N. Engl. J. Med. 325:473-478.
11. Basile, A.S. and Jones, E.A. (1997). Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 25:1303-1305.
12. A-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology 93:1069-1077.
13. Bassett, M.L., Mullen, K.D., Scholz, B., Fenstermacher, J. and Jones, E.A. (1990). Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Gastroenterology 98: 47-757.
14. Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M. and Petersen E.N. (1982). Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241-1243.
15. Butterworth, R.F., Giguère, J.-F., Michaud, J., Lavoie, J. and Pomier Layrargues, G. (1987). Ammonia: Key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1-12.
16. Conn, H.O. (1993). Hepatic encephalopathy. In: (L. Schiff and E.R.Schiff, eds). Diseases of the Liver. Lippincott, Philadelphia: 1036-1061.
17. Ferenci, P., Herneth, A. and Steindl, P. (1996). Newer approaches to therapy of hepatic encephalopathy. Semin. Liver Dis. 16:329-338.
18. Ferreira, M.R., Gammal, S.H. and Jones, E.A. (1997). Resistance to 3-mercaptopropionic acid-induced seizures in hepatic encephalopathy. Hepato-Gastroenterol. 44:766-769.
19. Flannery, D.B., Hsia, Y.E. and Wolf, B. (1982). Current status of hyperammonaemia syndromes. Hepatology 2:495-506.
20. Gammal, S.H., Basile, A.S., Geller, D., Skolnick, P. and Jones EA.(1990). Reversal of the behavioural and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 11:371-378.
21. A receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res. 720:35-44.
22. Itzhak, Y., Roig-Cantisano, A., Dombro, R.S. and Norenberg, M.D. (1995). Acute liver failure and hyperammonaemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain Brain Res. 705:345-348.
23. 3H]PK 11195. Neurosci. Lett. 177:35-38.
24. Itzhak, Y. and Norenberg, M.D. (1994b). Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfate. Neurosci .Lett. 182:251-254.
25. Jones, D.B., Mullen, K.D., Roessle, M., Maynard, T. and Jones, E.A. (1987). Hepatic encephalopathy: application of visual evoked responses to test hypotheses of its pathogenesis in rats. J. Hepatol. 4:118-126.
26. Jones, E.A., Yurdaydin, C. and Basile, A.S. (1994). The GABA hypothesis - State-of-the-art. Adv. Exp. Biol. Med. 368: 89-101.
27. A receptor function. Trends Pharmacol. Sci. 6:295-303.
28. Maddison, J.E., Dodd, P.R., Morrison, M., Johnson, G.A.R. and Farrell, G.C. (1987). Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy. Hepatology 7:621-628.
29. Majewska, M.D., Harrison, N.L., Schwartz, R.D,. Barker, J.L. and Paul, S.M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232:1004-1007.
30. Majewska, M.D. and Schwartz R.D. (1987). Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain? Brain Res. 404:355-360.
31. B binding sites in the cerebral cortex of rats with acute hepatic encephalopathy. Brain Res. 629:355-357.
32. Olasmaa, M., Rothstein, J.D., Guidotti, A., Weber, R.J., Paul, S.M., Spector, S. et al. (1990). Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J. Neurochem. 55:2015-2033.
33. Pappas, S.C., Ferenci, P., Schafer, D.F. and Jones, E.A. (1984). Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonaemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Gastroenterology 86:546-551.
34. Raabe, W.A. (1989). Neurophysiology of ammonia intoxication. In: (R.F. Butterworth and G. Pomier Layrarques, eds). Hepatic encephalopathy. Pathophysiology and Treatment. Humana, Clifton NJ, 49-77.
35. Rossle, M., Deckert, J. and Jones, E.A. (1989a). Autoradiographic analysis of GABA/ benzodiazepine receptors in an animal model of acute hepatic encephalopathy. Hepatology 10:143-147.
36. Rossle, M., Mullen, K.D. and Jones, E.A. (1989b). Cortical benzodiazepine receptor binding in a rabbit model of hepatic encephalopathy: the effect of Triton X-100 on receptor solubilization. Metab. Brain Dis. 4:203-212.
37. Roy, S., Pomier Layrargues, G., Butterworth, R.F. and Huet, P.-M. (1988). Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: Lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Hepatology 8:845-849.
38. Rzepczynski, D., Zieve, L., Lindblad, S. and LaFontaine, D. (1986). In vivo studies of GABAergic effects in experimental hepatic encephalopathy. Hepatology 5:902-905.
39. Schafer, D.F., Fowler, J.M., Brody, L.E. and Jones, E.A. (1980). Hepatic coma and inhibitory neurotransmission: the enteric bacterial flora as a source of gamma-aminobutyric acid. Gastroenterology 79:1052.
40. Schafer, D.F. and Jones, E.A. (1982). Hepatic encephalopathy and the gamma-aminobutyric acid neurotransmitter system. Lancet 1:18-20.
41. Schafer, D.F., Fowler, J.M., Munson, P.J., Thakur, A.K., Waggoner, J.G. and Jones, E.A. (1983). Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J. Lab. Clin. Med. 102:870-880.
42. Schafer, D.F., Pappas, S.C., Brody, L.E., Jacobs, R. and Jones, E.A. (1984). Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. Gastroenterology 86:540-545.
43. Scollo-Lavizzari, G. and Steinmann, E. (1985). Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1:1324.
44. Study, R. and Barker, J. (1981). Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. USA 77:7486-7472.
45. A response in dissociated rat cortical neurons. Neurosci. Lett. 151:51-54.
46. Willow, M. and Johnson, G.A.R. (1981). Dual action of pentobarbitone on GABA binding: role of binding site integrity. J. Neurochem. 37:1291-1294.